Zobrazeno 1 - 10
of 41
pro vyhledávání: '"G. I. Barbash"'
Autor:
Trevor D. Thompson, Michael A. Sloan, G I Barbash, Kenneth W. Mahaffey, Christopher B. Granger, M. L. Simoons, W D Weaver, E.J. Topol, Robert M. Califf, JM Gore, Harvey D. White
Publikováno v:
Circulation. 97:757-764
Background —Nonhemorrhagic stroke occurs in 0.1% to 1.3% of patients with acute myocardial infarction who are treated with thrombolysis, with substantial associated mortality and morbidity. Little is known about the risk factors for its occurrence.
Autor:
Eric J. Topol, Alan D. Guerci, Frank E. Harrell, G. I. Barbash, Robert M. Califf, Kerry L. Lee, Maarten L. Simoons, R.J. Simes, W D Weaver, Lynn H. Woodlief, Harvey D. White
Publikováno v:
American Heart Journal. 133:630-639
We developed a logistic regression model with data from the GUSTO-I trial to predict mortality rate differences in individual patients who received accelerated tissue plasminogen activator (TPA) versus streptokinase treatment for acute myocardial inf
Autor:
Oscar Kracoff, Natan Rougin, Chen Shapira, Nahum A. Freedberg, Eddy Barasch, Ehud Goldhammer, Hana Pauzner, Teddy Weiss, Shmuel Gottlieb, David Blondheim, Leonid Rudnik, Amos Katz, Fatchy Daka, Ron Narinsky, Hedy E. Faibel, Jamal Jafari, Menahem Kanetti, Arie Roth, G I Barbash, Alan Gelvan, Eldad Rechavia, Solomon Behar, Nabil Mahul, Hanoch Hod, Boaz Benari, Chaim Lotan, Mark Klutstein
Publikováno v:
The American Journal of Medicine. 101:184-191
PURPOSE: The aim of this study was to determine the proportion of patients with acute myocardial infarction (AMI) excluded from thrombolytic therapy on a national basis and to evaluate the prognosis of these patients by reasons of ineligibility and a
Publikováno v:
American Heart Journal. 130:453-458
The aim of our study was to compare the outcome of patients with a first acute myocardial infarction (AMI) among three large cohorts of patients hospitalized between 1966 and 1992 in Israel, in view of changes in treatment facilities and investigatio
Publikováno v:
Coronary Artery Disease. 5:1001-1008
BACKGROUND This study compares in-hospital and 1-year mortality rates in two large cohorts of patients with acute myocardial infarction (AMI) who were admitted to coronary care units in Israel in 1981-1983 and in 1992. Since the late 1960s and early
Autor:
Harvey D. White, E A Paolasso, T. van der Werf, G I Barbash, A Kristinsson, Michaela Modan, S Moulopoulos, Juhani Heikkilä, Rafael Diaz, John R. Hampton
Publikováno v:
Archives of Internal Medicine. 154:2237-2242
OBJECTIVE The outcome of patients with acute myocardial infarction who received thrombolytic therapy was assessed in relation to the size and comprehensiveness of cardiovascular services in the admitting hospitals. METHODS Two characteristics were ob
Autor:
Nabil Mahul, Menahem Kanetti, Eddy Barasch, Eldad Rechavia, David Blondheim, Amos Katz, Fatchy Daka, Alen Gelvan, Shmuel Gottlieb, Leonid Rudnik, Natan Rougin, Jamal Jafari, Solomon Behar, Chen Shapira, Tedi Weiss, G I Barbash, Nahum A. Freedberg, Hana Pauzner, Arie Roth, Ron Narinsky, Hedy E. Faibel, Ehud Goldhammer, Chaim Lotan, Mark Klutstein, Boaz Benari, Hanoch Hod, Oskar H. Kracoff
Publikováno v:
The American Journal of Cardiology. 73:438-443
A national study was performed in early 1992 in the 25 operating coronary care units in Israel, which enabled the assessment of whether the therapeutic management of patients with acute myocardial infarction was affected by patient gender. During a 2
Autor:
Michaela Modan, Frans Van de Werf, Streptokinase Mortality Trial, Harvey D White, G I Barbash
Publikováno v:
Journal of the American College of Cardiology. 22:707-713
Objectives. The purpose of this study was to evaluate the risks and benefits associated with thrombolytic theraphy in patients with diabetes presenting with acute myocardial infarction.Background. Diabetes mellitus is associated with adverse risk fac
Autor:
John R. Hampton, Michaela Modan, Rafael Diaz, T. van der Werf, A Kristinsson, E A Paolasso, G I Barbash, Juhani Heikkilä, S Moulopoulos, Harvey D. White
Publikováno v:
Circulation. 87:53-58
BACKGROUND Despite the fact that smoking is a well-established risk factor for the development of coronary artery disease, some investigators have noted that hospital mortality after acute myocardial infarction is lower in patients who smoke than in
Autor:
Michaela Modan, Frans Van de Werf, Harvey D White, Streptokinase Mortality Trial, G I Barbash
Publikováno v:
Journal of the American College of Cardiology. 20(1):36-41
The significance of antecedent angina in predicting clinical outcome was assessed in 8,329 patients with acute myocardial infarction who received thrombolytic therapy with either recombinant tissue-type plasminogen activator or streptokinase. There w